Cargando…

Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants

Objectives: The purpose of our study is to investigate the effects of apolipoprotein B (APOB) and APOE gene polymorphisms on bleeding complications in patients receiving direct oral anticoagulants (DOACs). Methods: A total of 16 single nucleotide polymorphisms (SNPs) in 468 patients were genotyped....

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Ha-Young, Song, Tae-Jin, Yee, Jeong, Park, Junbeom, Gwak, Hye-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501033/
https://www.ncbi.nlm.nih.gov/pubmed/36145636
http://dx.doi.org/10.3390/pharmaceutics14091889
_version_ 1784795371072913408
author Yoon, Ha-Young
Song, Tae-Jin
Yee, Jeong
Park, Junbeom
Gwak, Hye-Sun
author_facet Yoon, Ha-Young
Song, Tae-Jin
Yee, Jeong
Park, Junbeom
Gwak, Hye-Sun
author_sort Yoon, Ha-Young
collection PubMed
description Objectives: The purpose of our study is to investigate the effects of apolipoprotein B (APOB) and APOE gene polymorphisms on bleeding complications in patients receiving direct oral anticoagulants (DOACs). Methods: A total of 16 single nucleotide polymorphisms (SNPs) in 468 patients were genotyped. Six SNPs of ABCB1 (rs3842, rs1045642, rs2032582, rs1128503, rs3213619, and rs3747802), one SNP of CYP3A5 (rs776746), seven SNPs of APOB (rs1042034, rs2163204, rs693, rs679899, rs13306194, rs13306198, and rs1367117), and two SNPs of APOE (rs429358 and rs7412) were analyzed by a TaqMan genotyping assay. Multivariable logistic regression analysis with selected variables was performed for the construction of a risk scoring system. Two risk scoring systems were compared (demographic factors only vs. demographic factors and genetic factors). Results: In the multivariable analyses, two models were constructed; only demographic factors were included in Model I and both demographic factors and genetic factors in Model II. Rivaroxaban and anemia showed significant association with bleeding in both models. Additionally, ABCB1 rs3842 variant homozygote carriers (CC) and APOB rs13306198 variant allele carriers (AG, AA) had a higher risk of bleeding risk compared with that of wild-type allele carriers (TT, TC) and wild-type homozygote carriers (GG), respectively. Whereas the area under the receiver operating characteristic curve (AUROC) value using demographic factors only was 0.65 (95% confidence interval (CI): 0.56–0.74), the AUROC increased to 0.72 by adding genetic factors (95% CI: 0.65–0.80). The predicted bleeding risks of bleeding in patients with 0, 1, 2, 3, 4, 5, 6, 7 and 8 points from the logistic regression curve were 0.8%, 2.0%, 5.4%, 5.2%, 12.5%, 26.9%, 47.0%, 64.3% and 82.3%, respectively. Conclusions: The study results can be used for enhancing individualized treatment strategies in patients taking DOACs, helping clinicians predict the bleeding risk.
format Online
Article
Text
id pubmed-9501033
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95010332022-09-24 Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants Yoon, Ha-Young Song, Tae-Jin Yee, Jeong Park, Junbeom Gwak, Hye-Sun Pharmaceutics Article Objectives: The purpose of our study is to investigate the effects of apolipoprotein B (APOB) and APOE gene polymorphisms on bleeding complications in patients receiving direct oral anticoagulants (DOACs). Methods: A total of 16 single nucleotide polymorphisms (SNPs) in 468 patients were genotyped. Six SNPs of ABCB1 (rs3842, rs1045642, rs2032582, rs1128503, rs3213619, and rs3747802), one SNP of CYP3A5 (rs776746), seven SNPs of APOB (rs1042034, rs2163204, rs693, rs679899, rs13306194, rs13306198, and rs1367117), and two SNPs of APOE (rs429358 and rs7412) were analyzed by a TaqMan genotyping assay. Multivariable logistic regression analysis with selected variables was performed for the construction of a risk scoring system. Two risk scoring systems were compared (demographic factors only vs. demographic factors and genetic factors). Results: In the multivariable analyses, two models were constructed; only demographic factors were included in Model I and both demographic factors and genetic factors in Model II. Rivaroxaban and anemia showed significant association with bleeding in both models. Additionally, ABCB1 rs3842 variant homozygote carriers (CC) and APOB rs13306198 variant allele carriers (AG, AA) had a higher risk of bleeding risk compared with that of wild-type allele carriers (TT, TC) and wild-type homozygote carriers (GG), respectively. Whereas the area under the receiver operating characteristic curve (AUROC) value using demographic factors only was 0.65 (95% confidence interval (CI): 0.56–0.74), the AUROC increased to 0.72 by adding genetic factors (95% CI: 0.65–0.80). The predicted bleeding risks of bleeding in patients with 0, 1, 2, 3, 4, 5, 6, 7 and 8 points from the logistic regression curve were 0.8%, 2.0%, 5.4%, 5.2%, 12.5%, 26.9%, 47.0%, 64.3% and 82.3%, respectively. Conclusions: The study results can be used for enhancing individualized treatment strategies in patients taking DOACs, helping clinicians predict the bleeding risk. MDPI 2022-09-07 /pmc/articles/PMC9501033/ /pubmed/36145636 http://dx.doi.org/10.3390/pharmaceutics14091889 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yoon, Ha-Young
Song, Tae-Jin
Yee, Jeong
Park, Junbeom
Gwak, Hye-Sun
Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants
title Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants
title_full Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants
title_fullStr Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants
title_full_unstemmed Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants
title_short Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants
title_sort association between genetic polymorphisms and bleeding in patients on direct oral anticoagulants
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501033/
https://www.ncbi.nlm.nih.gov/pubmed/36145636
http://dx.doi.org/10.3390/pharmaceutics14091889
work_keys_str_mv AT yoonhayoung associationbetweengeneticpolymorphismsandbleedinginpatientsondirectoralanticoagulants
AT songtaejin associationbetweengeneticpolymorphismsandbleedinginpatientsondirectoralanticoagulants
AT yeejeong associationbetweengeneticpolymorphismsandbleedinginpatientsondirectoralanticoagulants
AT parkjunbeom associationbetweengeneticpolymorphismsandbleedinginpatientsondirectoralanticoagulants
AT gwakhyesun associationbetweengeneticpolymorphismsandbleedinginpatientsondirectoralanticoagulants